Drugs.com - Pharma Industry News

Risk of Obesity-Related Cancer Similar for GLP-1 Receptor Agonists and Bariatric Surgery

THURSDAY, May 15, 2025 -- Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may cut the risk of obesity-related cancer (ORC) in patients being treated for diabetes and obesity, according to a study published online May 11 in...

May 15, 2025 - 18:32
 0
Risk of Obesity-Related Cancer Similar for GLP-1 Receptor Agonists and Bariatric Surgery
THURSDAY, May 15, 2025 -- Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may cut the risk of obesity-related cancer (ORC) in patients being treated for diabetes and obesity, according to a study published online May 11 in...
Read More

Tags:

Previous Article

Some Triple Negative Breast Cancers Might Be Avoided by Longer Breastfeeding

Next Article

Gabapentinoids Not Directly Associated With Risk of Self-Harm

Related Posts

AAP Updates Guidance on Evaluation, Treatment of Patent Ductus Arteriosus in Preemies

AAP Updates Guidance on Evaluation, Treatment of Patent...

May 15, 2025  0

Nearly Half of Patients Seeking Vulvovaginal Disorder Care Report Negative Experiences

Nearly Half of Patients Seeking Vulvovaginal Disorder C...

May 13, 2025  0

Odds of Burnout Higher for Doctors Working With Incompletely Staffed Team

Odds of Burnout Higher for Doctors Working With Incompl...

May 15, 2025  0